AARP Rx Watchdog Report
By: Source: AARP.org Date Posted: 2006-01-31 16:23:00-05:00
The AARP Watchdog Report monitors the pricing, legislative and public policies of the world’s pharmaceutical manufacturers, and reports those policies, detrimental or beneficial, to our members and the American public. AARP is committed to advocating for responsible prescription drug prices through legal action, legislative policy and consumer education.
To view current or past issues, you will need a free Adobe Acrobat Reader.
Current Issue:
June 2007, Volume Four, Issue 5
D.C. Legislator Combats High Drug Costs
Past Issues:
May 2007, Volume Four, Issue 4
Hispanics and African Americans Troubled By High Cost of Prescription Drugs
April 2007, Special Edition
Minority of Senate Blocks Vote to Allow Medicare To Negotiate Lower Drug Prices
April 2007, Volume Four, Issue 3
The Man Who Really Watches Rx Drug Prices
March 2007, Volume Four, Issue 2
Brand-Name Drug Prices Climb Again in 2006
January 2007, Volume Four, Issue 1
Prices of Brand-Name Drugs Continue Their Steep Rise
October 2006, Volume Three, Issue 4
Prices of Brand-Name Drugs Continue to Rise Faster Than Inflation
September 2006, Special Edition
Prices of Brand-Name Drugs Continue to Rise Faster Than Inflation
July 2006, Volume Three, Issue 3
Price Hike by Brand-Name Drug Manufacturers Triples Inflation Rate
April 2006, Volume Three, Issue 2
Brand-Name Drug Prices Keep Going Up
February 2006, Volume Three, Issue 1
Once Again, Pharmaceutical Giants Hike Prices of Brand-Name Drugs Higher Than Inflation
November 2005, Volume Two, Issue 5
Brand-Name Drug Prices Continue Upward Trek
August 2005, Volume Two, Issue 3
Average Price Increase of Brand-Name Drugs More Than Doubles CPI
April 2005, Volume Two, Issue 2
2004 Increases in Manufacturers’ Prices for Brand-Name Drugs Reaches Five-Year High
February 2005, Volume Two, Issue 1
Evidence-Based Research: What the Rx Industry Might Not Want You to Know
December 2004, Volume One, Issue 5
AARP and New York Attorney General Join Forces on Drug Pricing
November 2004, Volume One, Issue 4
Changes in Manufacturers’ Price of Generics Vary Widely: AARP’s First Step in Monitoring Generic Market
September 2004, Volume One, Issue 3
Prescription Drugs: Right at Any Price?
July 2004, Volume One, Issue 2
AARP Backs Prescription Drug Import Legislation
Summer 2004, Volume One, Issue 1
Growth in Prescription Drug Prices Dramatically Outpaced Inflation 2000-2003
The AARP Watchdog Report monitors the pricing, legislative and public policies of the world’s pharmaceutical manufacturers, and reports those policies, detrimental or beneficial, to our members and the American public. AARP is committed to advocating for responsible prescription drug prices through legal action, legislative policy and consumer education.
To view current or past issues, you will need a free Adobe Acrobat Reader.
Current Issue:
June 2007, Volume Four, Issue 5
D.C. Legislator Combats High Drug Costs
Past Issues:
May 2007, Volume Four, Issue 4
Hispanics and African Americans Troubled By High Cost of Prescription Drugs
April 2007, Special Edition
Minority of Senate Blocks Vote to Allow Medicare To Negotiate Lower Drug Prices
April 2007, Volume Four, Issue 3
The Man Who Really Watches Rx Drug Prices
March 2007, Volume Four, Issue 2
Brand-Name Drug Prices Climb Again in 2006
January 2007, Volume Four, Issue 1
Prices of Brand-Name Drugs Continue Their Steep Rise
October 2006, Volume Three, Issue 4
Prices of Brand-Name Drugs Continue to Rise Faster Than Inflation
September 2006, Special Edition
Prices of Brand-Name Drugs Continue to Rise Faster Than Inflation
July 2006, Volume Three, Issue 3
Price Hike by Brand-Name Drug Manufacturers Triples Inflation Rate
April 2006, Volume Three, Issue 2
Brand-Name Drug Prices Keep Going Up
February 2006, Volume Three, Issue 1
Once Again, Pharmaceutical Giants Hike Prices of Brand-Name Drugs Higher Than Inflation
November 2005, Volume Two, Issue 5
Brand-Name Drug Prices Continue Upward Trek
August 2005, Volume Two, Issue 3
Average Price Increase of Brand-Name Drugs More Than Doubles CPI
April 2005, Volume Two, Issue 2
2004 Increases in Manufacturers’ Prices for Brand-Name Drugs Reaches Five-Year High
February 2005, Volume Two, Issue 1
Evidence-Based Research: What the Rx Industry Might Not Want You to Know
December 2004, Volume One, Issue 5
AARP and New York Attorney General Join Forces on Drug Pricing
November 2004, Volume One, Issue 4
Changes in Manufacturers’ Price of Generics Vary Widely: AARP’s First Step in Monitoring Generic Market
September 2004, Volume One, Issue 3
Prescription Drugs: Right at Any Price?
July 2004, Volume One, Issue 2
AARP Backs Prescription Drug Import Legislation
Summer 2004, Volume One, Issue 1
Growth in Prescription Drug Prices Dramatically Outpaced Inflation 2000-2003
preview